Shenzhen - Delayed Quote CNY
Ningbo David Medical Device Co., Ltd. (300314.SZ)
11.72
+0.07
+(0.60%)
At close: April 30 at 3:04:22 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
492,860.93
527,026.03
618,298.24
506,036.69
474,132.64
Cost of Revenue
216,937.63
229,413.07
262,451.94
209,739.94
182,201.64
Gross Profit
275,923.30
297,612.95
355,846.30
296,296.75
291,931
Operating Expense
225,672.01
224,552.69
212,626.86
199,497.77
218,674.56
Operating Income
50,251.30
73,060.27
143,219.44
96,798.98
73,256.45
Net Non Operating Interest Income Expense
8,737.59
9,853.34
13,612.61
4,769.50
2,642.45
Pretax Income
44,817.70
63,382.15
166,224.72
111,915.90
87,193.05
Tax Provision
3,093.95
6,118.84
18,613.81
14,557.30
6,986.35
Net Income Common Stockholders
41,723.75
57,263.31
147,610.91
97,358.60
80,206.69
Basic EPS
0.15
--
0.51
0.34
0.28
Diluted EPS
0.15
--
0.51
0.34
0.28
Basic Average Shares
286,270.68
--
289,433.16
286,348.83
286,452.47
Diluted Average Shares
286,270.68
--
289,433.16
286,348.83
286,452.47
Total Operating Income as Reported
50,145.52
68,794.06
171,364.66
112,010.17
87,226.81
Total Expenses
442,609.63
453,965.76
475,078.80
409,237.71
400,876.19
Net Income from Continuing & Discontinued Operation
41,723.75
57,263.31
147,610.91
97,358.60
80,206.69
Normalized Income
46,440.42
61,669.76
150,387.74
98,074.17
81,860.71
Interest Income
9,819.02
10,713.70
14,540.99
5,394.05
2,909.37
Interest Expense
779.59
472.11
598.81
350.31
32.77
Net Interest Income
8,737.59
9,853.34
13,612.61
4,769.50
2,642.45
EBIT
45,597.29
63,854.26
166,823.53
112,266.21
87,225.81
EBITDA
45,597.29
90,575.44
194,143.77
137,774.86
111,773.86
Reconciled Cost of Revenue
216,937.63
229,413.07
262,451.94
209,739.94
182,201.64
Reconciled Depreciation
--
26,721.18
27,320.24
25,508.65
24,548.04
Net Income from Continuing Operation Net Minority Interest
41,723.75
57,263.31
147,610.91
97,358.60
80,206.69
Total Unusual Items Excluding Goodwill
-5,066.42
-4,877.29
-3,126.99
-822.57
-1,798.09
Total Unusual Items
-5,066.42
-4,877.29
-3,126.99
-822.57
-1,798.09
Normalized EBITDA
50,663.71
95,452.74
197,270.76
138,597.43
113,571.94
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-349.76
-470.85
-350.16
-106.99
-144.07
12/31/2021 - 5/8/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade